Cavitation Technologies signs $35 million cash tender offer deal with BrightFlixx Finance Luxembourg
CVAT•CVAT•CVAT•CVAT•BrightFlixx Finance (Luxembourg) signed definitive purchase agreements for all outstanding shares of Cavitation Technologies’ common stock. Proposed cash consideration totals $42 million, including $35 million for Cavitation Technologies and $7 million for Alchemy Beverages.
BrightFlixx Finance (Luxembourg) signed definitive purchase agreements covering all outstanding shares of Cavitation Technologies’ common stock. The proposed aggregate cash consideration is $42 million, with $35 million allocated to Cavitation Technologies and $7 million to Alchemy Beverages.
The new agreements replace prior tender offer arrangements with European Guarantee Services, which were terminated. Financing remains backed by Bright Wealth Banking, the same institution involved in the earlier transaction.
